Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
06 April 2022
Lista per la nomina del Collegio Sindacale
06 April 2022
Explanatory Memorandum on Authorisation to purchase and use trasury shares
06 April 2022
REPORT ON THE REMUNERATION POLICY AND THE REMUNERATION PAID
31 March 2022
ANNUAL FINANCIAL STATEMENTS 31/12/2021
31 March 2022
Report on Corporate Governance and Ownership structure
28 March 2022
Explanatory Memorandum on Remuneration Policy
28 March 2022
Explanatory Memorandum on Financial Statements 2021
22 March 2022
TP ICAP MIDCAP RESEARCH 22/03/2022
21 March 2022
INTERMONTE RESEARCH 21/03/2022
21 March 2022
ALANTRA RESEARCH 21/03/2022
18 March 2022
Proxy form ex art 135 undecies
18 March 2022
Proxy form ex art 135 novies
<
1
…
5
6
7
…
16
>